<!-- <h2>NCI Surgery Branch - 3 West Tumor Infiltrating Leukocyte (TIL) Lab </h2> -->
<p> The National Institutes of Health (NIH) National Cancer Institute (NCI) Surgery Branch operates the 3-West
  facility for the manufacture of Phase I and II clinical materials to support the development of autologous Tumor
  Infiltrating Leukocyte (TIL) cell therapies. The facility complies with current Good Manufacturing Practices (cGMP).
  The space is approximately 796 gross square feet and is located on the 3rd floor of the southwest wing of the
  Clinical Research Center in Building 10. </p>

<p>
  The facility consists of one (1) ISO 7 positively pressurized processing room and one (1) ISO 8 gowning/de-gowning
  anteroom. An ISO 5 environment for work is maintained in the Biological Safety Cabinets.
</p>
<p>
  The processing room is designed to provide a multi-directional flow of personnel, equipment, and materials.
</p>
<p>
  The mechanical systems include two (2) air handling units and approximately three (3) terminal air units that will
  supply and control air changes, temperature, humidity and differential pressure. All supply air to the classified
  rooms is HEPA filtered. The exhaust system ties to the laboratory exhaust system.
</p>